ZWI Trademark

Trademark Overview

On Monday, November 25, 2019, a trademark application was filed for ZWI with the United States Patent and Trademark Office. The USPTO has given the ZWI trademark a serial number of 88705587. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 15, 2024. This trademark is owned by ZWI Therapeutics, Inc.. The ZWI trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

House mark for pharmaceutical preparations; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies

Pharmaceutical research and development services
zwi

General Information

Serial Number88705587
Word MarkZWI
Filing DateMonday, November 25, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements

Goods and ServicesHouse mark for pharmaceutical preparations; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies
Goods and ServicesPharmaceutical research and development services

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 4, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZWI Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameZWI Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Thursday, November 28, 2019NEW APPLICATION ENTERED
Wednesday, December 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 27, 2020ASSIGNED TO EXAMINER
Thursday, February 27, 2020NON-FINAL ACTION WRITTEN
Thursday, February 27, 2020NON-FINAL ACTION E-MAILED
Thursday, February 27, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 24, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 25, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 26, 2020FINAL REFUSAL WRITTEN
Wednesday, August 26, 2020FINAL REFUSAL E-MAILED
Wednesday, August 26, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, February 12, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 12, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 12, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 12, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, February 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 10, 2021SOU TEAS EXTENSION RECEIVED
Friday, September 10, 2021SOU EXTENSION 1 FILED
Friday, September 10, 2021SOU EXTENSION 1 GRANTED
Tuesday, September 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2022SOU TEAS EXTENSION RECEIVED
Monday, March 21, 2022SOU EXTENSION 2 FILED
Monday, March 21, 2022SOU EXTENSION 2 GRANTED
Wednesday, March 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 8, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 8, 2022SOU EXTENSION 3 FILED
Tuesday, November 8, 2022SOU EXTENSION 3 GRANTED
Thursday, November 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 5, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 5, 2023SOU EXTENSION 4 FILED
Monday, June 5, 2023SOU EXTENSION 4 GRANTED
Wednesday, June 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 30, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, December 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2023SOU EXTENSION 5 FILED
Wednesday, December 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 14, 2023SOU EXTENSION 5 GRANTED
Friday, December 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 15, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 15, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

pharmaceutical preparations prevention human treatment ophthalmological nephrological genitourinary dermatological gastrointestinal